1 patient evaluation for ALS Phase 2 Study KNS-760704 CL201
Sort by:
Most recent
Oct 24, 2009 (Started Jul 01, 2008)
-
EffectivenessMajor (for Participate in clinical trial)
-
EffectivenessCan't tell (for amyotrophic lateral sclerosis)
-
Side effectsNone
-
AdherenceAlways
-
BurdenSomewhat hard to take
Dosage:
300 mg
Daily
Advice & Tips:
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost:
< $25 monthly
- 4 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for ALS Phase 2 Study KNS-760704 CL201